mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-10 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |